Abstract
The pathogenesis of chronic rhinosinusitis (CRS) is multi-factorial with an infectious process likely at least partly involved. While bacteria have been proposed to play a critical role in CRS, fungi have also been implicated by some investigators, although the pathogenesis of fungi in CRS represents a significant controversy among rhinologists. Fungal-associated factors believed to be involved in CRS include the ability of fungi to induce significant inflammatory reactions by different means through inducing localized cytokine production in the sinonasal tract. Despite these observations, randomized, controlled studies on CRS patients using antifungal therapy have not resulted in significant improvement in CRS patients. The role of fungi in the pathogenesis of CRS remains controversial.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Wood AJ, Douglas RG. Pathogenesis and treatment of chronic rhinosinusitis. Postgrad Med J. 2010;86:359–64. This is a great review on the factors believed to be important in the pathogenesis of CRS.
Kern RC, Conley DB, Walsh W, et al. Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. Am J Rhinol. 2008;22:549–59.
•• Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on Rhinosinusitis and nasal polyps 2012. Rhinology. 2012;50(supplement 23):1–298. This is an excellent, exhaustive overview of sinusitis with details on the diagnosis, pathogenesis, and management.
Fakhri S, Frenkiel S, Hamid QA. Current views of the molecular biology of chronic sinusitis. J Otolaryngol. 2002;31 suppl 1:S2–9.
Stephenson AR, Leid JG, Hunsaker D. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope. 2006;1116:1121–6.
Davis LB, Kita H. Pathogenesis of chronic rhinosinusitis: role of airborne fungi and bacteria. Immunol Allergy Clin N Am. 2004;24:59–73.
Brook I. Chronic sinusitis in children and adults: role of bacteria and antimicrobial management. Curr Allergy Asthma Rep. 2005;5(6):482–90.
Fraser JD, Proft TL. The bacterial superantigen and superantigen-like proteins. Immunol Rev. 2008;225:226–43.
Wang M, Shi P, Chen B, Zhang H, Jian J, Chen X, Wang Z, Zhang D. The role of superantigens in chronic rhinosinusitis with nasal polyps. Otorhinolaryngol Relat Spec. 2008;70(2):97–103.
Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999;74:877–84.
• Orlandi RR, Marple BF. The role of fungus in chronic rhinosinusitis. Otolaryngol Clin N Am. 2010;43:531–7. An excellent rebuttal to Ponikau’s 1999 study.
Ebbens FA, Fokkens WJ. The mold conundrum in chronic rhinosinusitis: where do we stand today? Curr Allergy Asthma Rep. 2008;8(2):93–101.
Ebbens FA, Georgalas C, Fokkens WJ. Fungus as the cause of chronic rhinosinusitis: the case remains unproven. Curr Opin Otolaryngol Head Neck Surg. 2009;17(1):43–9.
Braun H, Buzina W, Freudenschuss K, Beham A, Stammberger H. Eosinophilic fungal Rhinosinusitis: a common disorder in Europe? Laryngoscope. 2003;113(2):264–9.
•• Bassiouny A, Ragab A, Attia AF, et al. Prevalence of extramucosal fungal elements in sinonasal polyposis: a mycological and pathologic study in en Egyptian population. Am J Otolaryngol Head Neck Med Surg. 2011;32:307–17. A recent study supporting Ponikau’s original study.
Lackner A, Stammberger H, Buzina W, et al. Fungi: a normal content of human nasal mucus. Am J Rhinol. 2005;19:125–9.
•• Murr AH, Goldberg AN, Pletcher SD, Dillehay K, Wymer LJ, Vesper SJ. Some chronic rhinosinusitis patients have elevated populations of fungi in their sinuses. Laryngoscope. 2012;122:1438–45. An additional study supporting fungi in the pathogenesis of CRS and indicating that perhaps the correct antifungals have not be utilized in prior studies.
Eyigor H, Eyigor M, Gunel C, Gultekin, Basak S, Aydin N. Characterization of fungi in chronic rhinosinusitis using polymerase chain reaction and sequencing. Eur Arch Otorhinolaryngol. 2008;265:651–5.
• Montone KT, Livolsi VA, Feldman MD, Palmer J, Chiu AG, Lanza DC, Kennedy DW, Loevner LA, Nachamkin I. Int J Otolaryngol. 2012;2012:684835. Fungal rhinosinusitis: a retrospective microbiologic and pathologic review of 400 patients at a single university medical center. An overview of 400 patients with fungal sinusitis in the North Eastern US.
Manning SC, Holman M. Further evidence for allergic pathophysiology in allergic fungal sinusitis. Laryngoscope. 1998;108:1485–96.
Granville L, Chirala M, Cernoch P, Ostrowski M, Truong LD. Fungal sinusitis: histologic spectrum and correlation with culture. Hum Pathol. 2004;35:474–81.
Taxy J. Paranasal fungal sinusitis: contributions of histopathology to diagnosis: a report of 60 cases and literature review. Am J Surg Pathol. 2006;30(6):713–20.
Chakrabarti A, Denning DW, Ferguson BJ, et al. Fungal rhinosinusitis: a categorization and definitional scheme addressing current controversies. Laryngoscope. 2009;119:1809–18.
Bent JP, Kuhn F. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1994;111:580–8.
de Shazo RD, Chapin K, Swain RE. Fungal sinusitis. New Eng J Med. 1997;337(4):254–9.
Schubert MS. Allergic fungal sinusitis: pathophysiology, diagnosis and management. Med Mycol. 2009;47 suppl 1:S324–330.
Shin SH, Poinikau JU, Sherris DA, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol. 2004;114:1369–75.
Ferguson BJ. Eosinophilic mucin Rhinosinusitis: a distinct clinicopathologic entity. Laryngoscope. 2000;110(5):799–813.
•• Guo C, Ghaderoshi S, Kephart GM, et al. Improving the detection of fungi in eosinophilic mucin: seeing what we could not see before. Otolaryngol Head Neck Surg. 2012;147(5):943–9. An interesting study showing that by using protease pretreatment of eosinophilic mucin that routine GMS stains will pick up more fungi.
Healy DY, Leid JG, Sanderson AR, Hunsaker DH. Biofilms with fungi in chronic Rhinosinusitis. Otolaryngol Head Neck Surg. 2008;138:641–7.
Orlandi RR, Thibeault SL, Ferguson BJ. Microarray analysis of allergic fungal sinusitis and eosinophilic muin rhinosinusitis. Otolarnygol Head Neck Surg. 2007;136(5):707–13.
Schubert MS, Hutcheson PS, Graff RJ, Santiago L, Slavin RG. HLA-DQB1 *03 in allergic fungal sinusitis and other chronic hypertrophic rhinosinusitis disorders. J Allergy Clin Immunol. 2004;114:1376–83.
Das S, Maeso PA, Becker AM, Prosser JD, Adam B-L, Kountakis SE. Proteomics blood testing to distiguish chronic rhinosinusitis subtypes. Laryngoscope. 2008;118:2231–4.
Oncel S, Pinar E, Sener G, Calli C, Karagoz U. Evaluation of bacterial biofilms in chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2010;39(1):52–5.
Orlandi RR, Marple BF, Georgelas A, et al. Immunologic response to fungus is not universally associated with rhinosinusitis. Otolarnygol Head Neck Surg. 2009;141:750–6.
•• Sacks PL, Harvey, Rimmer J, Gallagher RM, Sacks R. Antifungal therapy in the treatment of chronic Rhinosinusitis: a meta analysis. Am J Rhinol Allergy. 2012;26:141–7. An overview of a series of randomized, controlled studies of antifungal therapy in CRS.
Ebbens F, Bachert C, Mullol J, et al. Amphotericin B nasal lavages equally as effective as placebo. Clin Otolaryngol Allied Sci. 2006;31:169.
Chan KO, Genoway KA, Javer AR. Effectiveness of itraconazole in the management of refractory allergic fungal rhinosinusitis. J Otolaryngol Head Neck Surg. 2008;37:870–4.
Stankiewicz JA, Musgrave BK, Scianna JM. Nasal amphotericin irrigation in chronic Rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2008;16:44–6.
Lal D, Stankiewicz JA. Antifungal treatment and chronic rhinosinusitis. Curr Allergy Asthma Rep. 2009;9:227–31.
Gerlinger I, Fittler A, Fonai F, et al. Post operative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis with a review of antifungal therapy. Eur Arch Otorhinolaryngol. 2009;266:847–55.
Liang KL, Su MC, Shiao, et al. Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo controlled double blind study. Am J Rhinol. 2008;22:52–8.
Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo controlled, double blind pilot trial. J Allergy Clin Immunol. 2005;115:125–31.
Kennedy DW, Kuhn FA, Hamilos, et al. Treatment of chronic rhinosinusitis with high dose oral terbinafine: a double blind, placebo controlled study. Laryngoscope. 2005;115:1793–9.
Weschta M, Rimek D, Formanek M, et al. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized double blind clinical trial. J Allergy Clin Immunol. 2004;113:1122–8.
Rank MA, Adolphson CR, Kita H. Antifungal therapy for chronic rhinosinusitis: the controversy persists. Curr Opin Allergy Clin Immunol. 2009;9:67–72.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Montone, K.T. Role of Fungi in the Pathophysiology of Chronic Rhinosinusitis: An Update. Curr Allergy Asthma Rep 13, 224–228 (2013). https://doi.org/10.1007/s11882-012-0332-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-012-0332-x